AIMZ Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.53M Sell
12,884
-60
-0.5% -$21.4K 1.4% 19
2025
Q4
$4.24M Sell
12,944
-88
-0.7% -$27.9K 1.21% 29
2025
Q3
$3.68M Sell
13,032
-88
-0.7% -$25.5K 1.15% 28
2025
Q2
$3.66M Sell
13,120
-99
-0.7% -$28K 1.23% 27
2025
Q1
$4.12M Buy
13,219
+2
+0% +$591 1.44% 24
2024
Q4
$3.44M Sell
13,217
-148
-1% -$43.9K 1.2% 27
2024
Q3
$4.31M Sell
13,365
-174
-1% -$56.9K 1.47% 22
2024
Q2
$4.23M Sell
13,539
-153
-1% -$44.9K 1.52% 19
2024
Q1
$3.89M Sell
13,692
-423
-3% -$124K 1.45% 19
2023
Q4
$4.07M Sell
14,115
-156
-1% -$42.5K 1.65% 14
2023
Q3
$3.84M Sell
14,271
-99
-0.7% -$24.7K 1.71% 17
2023
Q2
$3.19M Buy
14,370
+2
+0% +$464 1.37% 23
2023
Q1
$3.47M Sell
14,368
-73
-0.5% -$17.9K 1.56% 20
2022
Q4
$3.79M Sell
14,441
-423
-3% -$113K 1.79% 16
2022
Q3
$3.35M Sell
14,864
-24
-0.2% -$5.82K 1.7% 18
2022
Q2
$3.62M Sell
14,888
-68
-0.5% -$16.7K 1.74% 18
2022
Q1
$3.62M Sell
14,956
-398
-3% -$91.4K 1.49% 20
2021
Q4
$3.45M Buy
15,354
+401
+3% +$84.6K 1.34% 25
2021
Q3
$3.18M Sell
14,953
-26
-0.2% -$5.98K 1.44% 19
2021
Q2
$3.65M Sell
14,979
-42
-0.3% -$10.3K 1.64% 17
2021
Q1
$3.74M Sell
15,021
-158
-1% -$37.7K 1.83% 15
2020
Q4
$3.49M Buy
15,179
+1
+0% +$231 1.83% 15
2020
Q3
$3.86M Sell
15,178
-184
-1% -$45.6K 2.31% 10
2020
Q2
$3.62M Sell
15,362
-73
-0.5% -$16.7K 2.35% 9
2020
Q1
$3.13M Sell
15,435
-174
-1% -$38K 2.43% 9
2019
Q4
$3.76M Sell
15,609
-349
-2% -$76.9K 2.44% 8
2019
Q3
$3.09M Sell
15,958
-372
-2% -$71.4K 2.13% 14
2019
Q2
$3.01M Buy
16,330
+1
+0% +$179 2.08% 16
2019
Q1
$3.1M Buy
16,329
+2
+0% +$382 2.13% 16
2018
Q4
$3.18M Sell
16,327
-627
-4% -$122K 2.45% 12
2018
Q3
$3.51M Sell
16,954
-799
-5% -$157K 2.26% 11
2018
Q2
$3.28M Sell
17,753
-99
-0.6% -$17.5K 2.32% 11
2018
Q1
$3.04M Sell
17,852
-198
-1% -$36.3K 2.21% 11
2017
Q4
$3.14M Sell
18,050
-73
-0.4% -$12.9K 2.36% 9
2017
Q3
$3.38M Buy
18,123
+1
+0% +$177 2.77% 6
2017
Q2
$3.12M Buy
18,122
+2
+0% +$325 2.62% 6
2017
Q1
$2.97M Sell
18,120
-24
-0.1% -$3.99K 2.51% 10
2016
Q4
$2.65M Buy
18,144
+8
+0% +$1.2K 2.37% 11
2016
Q3
$3.02M Sell
18,136
-1,424
-7% -$241K 2.71% 8
2016
Q2
$2.98M Sell
19,560
-19,998
-51% -$3.11M 2.73% 4
2016
Q1
$6.13M Buy
39,558
+19,644
+99% +$2.92M 2.7% 7
2015
Q4
$3.23M Buy
19,914
+1
+0% +$157 2.95% 5
2015
Q3
$2.75M Buy
19,913
+101
+0.5% +$15.9K 2.53% 9
2015
Q2
$3.04M Buy
19,812
+70
+0.4% +$11.2K 2.64% 7
2015
Q1
$3.16M Buy
19,742
+51
+0.3% +$8.03K 2.7% 8
2014
Q4
$3.14M Buy
+19,691
New +$3.07M 2.8% 8

Other funds holding AMGN

AIMZ Investment Advisors's AMGN Position: Q1 2026 in Review

AIMZ Investment Advisors reduced its Amgen (AMGN) stake by 0.46% in Q1 2026, selling an estimated $21.4K and leaving 12,884 shares worth $4.53M. The position accounts for 1.4% of the portfolio, ranked #19.

AIMZ Investment Advisors first reported a position in AMGN in Q4 2014 and has held it in 46 quarters since. The position peaked at $6.13M in Q1 2016. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • AIMZ Investment Advisors held 12,884 shares of Amgen worth $4.53M as of Q1 2026.
  • AIMZ Investment Advisors sold 60 Amgen shares in Q1 2026, an estimated $21.4K.
  • Amgen made up 1.4% of AIMZ Investment Advisors's portfolio in Q1 2026, its #19 holding.
  • AIMZ Investment Advisors first reported a position in Amgen in Q4 2014 and has held it in 46 quarters since.
  • AIMZ Investment Advisors's Amgen position peaked at $6.13M in Q1 2016.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on AIMZ Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.